Actinobac Biomed actinobac.com


Public list: BIO 2016 (619) Pharma Startups (4732) Cancer Therapeutics (1137) Eye Health (692)

Actinobac Biomed is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV. Its drug candidates are based upon Leukothera (LtxA), a natural protein that targets and eliminates white blood cells (WBCs) involved in the mechanism of many diseases. Products based upon Leukothera are being developed by Actinobac for the treatment of leukemia/lymphoma, dry eye, and psoriasis.

Actinobac Biomed is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV. Its drug candidates are based upon Leukothera (LtxA), a natural protein that targets...Show all

Company (Alive / Active)

Phone: 732-371-2694

Fax: 732-745-7270

15 Pelham Road

Kendall Park, 08824
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Actinobac Biomed $5.1M Jun 8, 2018
See all 58 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Actinobac Biomed Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Foundation Venture Capital GroupVenture CapitalNew Brunswick, New Jersey, United StatesUnattributed VC, Seed VC - II, Seed VC
National Institutes of HealthGovernmentBethesda, Maryland, United StatesGrant
National Cancer InstituteGovernmentBethesda, Maryland, United StatesGrant - II
Kairos VenturesVenture CapitalBeverly Hills, California, United StatesSeed VC - III
See all 4 investors

Competitors

Company Status Description Investors
See all 58 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Treatment and diagnosis of ocular disease Jun 27, 2014 Apr 24, 2018 Patent
Treatment and diagnosis of inflammatory disorders and hiv Mar 24, 2016 Dec 26, 2017 Patent
Methods to treat inflammation of the lung Jun 19, 2015 Aug 08, 2017 Patent
Combination therapy with leukotoxin Mar 16, 2012 May 31, 2016 Patent
Treatment and diagnosis of inflammatory disorders and hiv Dec 06, 2017 Application